Row
J
JAZZAI Stock Diagnostic Report
Jazz Pharmaceuticals announces private offering of $1B of exchangeable senior notes due 2032 and concurrent share repurchases
Jazz Pharmaceuticals announced the issuance of convertible bonds maturing in 2032 and a share buyback.
View Source Article ↗AI CATALYST SCORE50 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time